CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide. This commitment is reflected in our support of programmes and activities for patients with rare plasma-protein related diseases, including bleeding disorders and primary immune deficiencies.
Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk . Adverse events should also be reported to CSL Behring UK Ltd. on 01444 447 405.
If you would like to contact CSL Behring for any other reason, please visit our Contact page to find the appropriate details.